Supernus Share Price
NASDAQ: SUPN | Small Cap | HealthcareSupernus Stock Performance
Supernus Share Price Today
As of 19 November 2026, Supernus, Inc.'s share price is $28.98. The stock opened at $29.00, compared to its previous close of $29.07. During today's trading session, Supernus, Inc.'s share price traded between $28.71 and $29.75, with an average price of $29.23. Over the past 52 weeks, the stock has recorded a high of $59.45 and a low of $25.93. In terms of performance, Supernus, Inc.'s share price has declined by 37.20% over the last six months and is down 36.58% on a year-on-year basis.
Supernus Share Price Chart
Supernus Quarterly Profit & Loss
All figures in USD
Supernus Annual Profit & Loss
All figures in USD
Supernus Balance Sheet
All figures in USD Million
Supernus Cash Flow
All figures in USD Million
Corporate Actions
About Supernus
Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.
Supernus Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $28.60 | $28.97 | -30.86% |
Oct 2026 | $43.23 | $41.90 | -2.77% |
Sep 2026 | $44.52 | $43.09 | -2.48% |
Aug 2026 | $50.45 | $44.19 | -0.99% |
Jul 2026 | $46.95 | $44.63 | -4.08% |
Jun 2026 | $46.02 | $46.53 | +0.85% |
May 2026 | $47.81 | $46.14 | -3.87% |
Apr 2026 | $51.37 | $48.00 | -7.12% |
Mar 2026 | $54.52 | $51.68 | -5.64% |
Feb 2026 | $48.63 | $54.77 | +13.70% |
Jan 2026 | $49.27 | $48.17 | -3.03% |
Dec 2025 | $45.45 | $49.67 | +8.72% |